184
Participants
Start Date
May 19, 2021
Primary Completion Date
January 25, 2024
Study Completion Date
December 31, 2025
BNT111
IV injection
Cemiplimab
IV infusion
Melanoma Institute Australia, Sydney
Border Medical Oncology, East Albury
Gold Coast Hospital, Southport
Hospital Universitari Germans Trias i Pujol (HUGTP), Badalona
Fondazione del Piemonte per l'Oncologia, Istituto di Candiolo (IRCCs), Candiolo
AOU Citta della Salute e della Scienza di Torino, Turin
Hospital Teresa Herrera (CHUAC), A Coruña
Complejo Hospitalario Universitario De Santiago De Compostela, Santiago de Compostela
Inova Dwight and Martha Schar Cancer Institute, Fairfax
Universitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel Hautkrebszentrum Kiel, Kiel
Hospital General Universitario Gregorio Maranon, Madrid
MD Anderson Cancer Center, Madrid
Hospital Universitario Puerta de Hierro - Majadahonda, Madrid
Klinik für Dermatologie, Dermatochirurgie, Allergologie, Klinikum Bremen-Ost, Gesundheitnord GmbH, Bremen
Hospital Universitario Virgen de la Arrixaca, El Palmar
Sylvester Comprehensive Cancer Center/ UMHC, Miami
IOV - Istituto Oncologico Veneto - IRCCS, Padua
Hospital Universitario Marques De Valdecilla, Santander
Azienda ospedaliera universitaria Bologna, Bologna
Hospital Universitario Virgen del Rocio, Seville
Universitätsklinikum Essen (AoR), Essen
Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumpori (IRST), Meldola
Universita di Siena -Azienda Ospedaliera Universitaria Senese-Policlincio Santa Maria Alle Scotte, Siena
Universitätsmedizin der Johannes Gutenberg Universität Mainz KoeR, Mainz
Universitätsklinikum Mannheim GmbH, Mannheim
Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Universitätsklinikum Heidelberg, Heidelberg
Istituto Di Ricovero E Cura A Carattere Scientifico - Istituto Tumori Giovanni Paolo Ii, Bari
University Hospital Tübingen, Tübingen
Universitätsklinikum Freiburg, Klinik füer Dermatologie und Venerologie, Freiburg im Breisgau
Istituto Nazionale Tumori Fondazione Pascale - IRCCS · S.C. Oncologia Medica Melanoma, Immunoterapia Oncologica e Terapie Innovative, Napoli
Uniwersyteckie Centrum Kliniczne, Gdansk
University Of Arizona College Of Medicine, Tucson
Klinikum Nürnberg Nord, Nuremberg
Klinikum der Julius-Maximilians-Universität Würzburg, Würzburg
University of California, San Francisco: Helen Diller Family Comprehensive Cancer Center, San Francisco
Atlantic Health System / Morristown Medical Center, Morristown
Universitätsklinikum Leipzig, Leipzig
Policlinico Universitario Campus Bio-Medico, Rome
Szpital Specjalistyczny im. Luwika Rydygiera w Krakowie Sp. z o.o., Krakow
Zachodniopomorskie Centrum Onkologii, Szczecin
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warsaw
Hospital Clinic de Barcelona, Barcelona
Hospital De La Santa Creu I Sant Pau, Barcelona
Institut Català d'Oncologia l'Hospitalet, Barcelona
Beatson West of Scotland Cancer Centre - Greater Glasgow Health Board, Glasgow
The Christie - The Christie NHS Foundation Trust, Manchester
Royal Cornwall Hospital, Truro
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
BioNTech SE
INDUSTRY